Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.

NCT02316717 is registered in ClinicalTrials.gov with Immuron Ltd. as lead sponsor.

NCT NCT02316717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02316717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Lead sponsor
Immuron Ltd.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2014
Completion date
October 30, 2017
Enrollment
133 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic steatohepatitis (nash)